SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-10-041379
Filing Date
2010-08-05
Accepted
2010-08-05 08:48:59
Documents
2
Period of Report
2010-07-30

Document Format Files

Seq Description Document Type Size
1 v192518_ex.html 3  
1 v192518_ex.xml 3 2160
2 v192518_e24-1.htm EX-24.1 11671
  Complete submission text file 0001144204-10-041379.txt   15669
Mailing Address 135 BEAVER ST WATHAM MA 02452
Business Address 135 BEAVER ST WATHAM MA 02452 1-781-398-0700
INTERLEUKIN GENETICS INC (Issuer) CIK: 0001037649 (see all company filings)

IRS No.: 943123681 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O INTERLEUKIN GENETICS, INC. 135 BEAVER STREET WALTHAM MA 02452
Business Address
Ehrenberger Catherine (Reporting) CIK: 0001498300 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-32715 | Film No.: 10992809